Updated 22 hours ago
Last progress March 6, 2025 (11 months ago)
SUPPORT for Patients and Communities Reauthorization Act of 2025
Updated 2 days ago
Last progress December 1, 2025 (2 months ago)
Lower Costs for Everyday Americans Act
Updated 2 days ago
Last progress March 3, 2025 (11 months ago)
SUPPORT for Patients and Communities Reauthorization Act of 2025
Updated 2 days ago
Last progress June 18, 2025 (7 months ago)
Adds “podiatric medicine” to the list of medical fields named in the Controlled Substances Act’s medical education curriculum provisions and makes minor subsection lettering adjustments. The change is applied retroactively, taking effect as if enacted on December 29, 2022.
Redesignate the second subsection previously designated as subsection (l) of Section 303 (21 U.S.C. 823) as subsection (m).
In the subsection that becomes subsection (m)(1), subparagraph (A), clause (v): strike the phrase "osteopathic medicine, dental surgery" and insert "osteopathic medicine, podiatric medicine, dental surgery."
In the same clause (v), strike the phrase "or dental medicine curriculum" and insert "or dental or podiatric medicine curriculum."
Make additional textual edits within subsection (m)(1) as redesignated: in subparagraph (A) (clause (iv) and its subclauses) and in subparagraph (B) (clauses (i) and (ii)) the section lists specific insertions and strikes (insertions before or after punctuation and replacement of phrases), as shown in the text. The provision lists the places where text is to be inserted or struck but the section presents those edits in clause-level detail.
Effective date: The amendments made by subsection (a) shall take effect as if enacted on December 29, 2022.
Primary effects are administrative and clarifying. Podiatric medical schools and podiatry students gain explicit statutory recognition in the Controlled Substances Act’s curriculum language, which can affect how agencies and accreditors cite or interpret training requirements. Medical schools, accrediting bodies, licensing boards, and federal agencies that implement or rely on the statute may need to update guidance, forms, and internal references to reflect the new wording and subsection lettering. There is no direct funding, new program creation, or change to licensing or prescribing authority built into the amendment; any substantive changes would depend on later agency or accreditor actions. The retroactive effective date reduces ambiguity about how the law should be applied to actions taken after December 29, 2022.
Last progress March 11, 2025 (11 months ago)
Introduced on March 11, 2025 by Michael F. Bennet
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.